Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung CancerRamaswamy Govindan, Martin Reck, Jacek Jassem et al.|Journal of Clinical Oncology|2017Cited by 380
Consensus for HER2 alterations testing in non-small-cell lung cancerShengxiang Ren, Fred R. Hirsch, Jiong Wang et al.|ESMO Open|2022Cited by 110
A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)Xingsheng Hu, Yan Sun, Baohui Han et al.|Lung Cancer|2014Cited by 51
Multi‐target angiogenesis inhibitor combined with <scp>PD</scp>‐1 inhibitors may benefit advanced non‐small cell lung cancer patients in late line after failure of <scp>EGFR‐TKI</scp> therapyLian Yu, Runbo Zhong, Yaohua Hu et al.|International Journal of Cancer|2023Cited by 25
PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathwayWei Zhang, Baohui Han|Cancer Cell International|2021Cited by 22